Canaccord Starts Pharming Group (PHAR) at Buy, PT $37
Tweet Send to a Friend
Canaccord analyst Whitney Ijem initiates coverage on Pharming Group (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


